Sequential therapy with activated prothrombin complex concentrate (FEIBA) and recombinant factor VIIa in a patient with severe haemophilia A, inhibitor presence and refractory bleeding.
Economou
M
M
Teli
A
A
Tzantzaroudi
A
A
Tsatra
I
I
Zavitsanakis
A
A
Athanassiou-Metaxa
M
M
D000293:Adolescent; D001062:Appendectomy; D001323:Autoantibodies / Q000097:blood; D001779:Blood Coagulation Factors / Q000008:administration & dosage* / Q000627:therapeutic use; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D005169:Factor VIII / Q000276:immunology; D015942:Factor VIIa / Q000008:administration & dosage* / Q000627:therapeutic use; D006467:Hemophilia A / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000276:immunology; D006801:Humans; D008297:Male; D019106:Postoperative Hemorrhage / Q000000981:diagnostic imaging / Q000188:drug therapy*; D011994:Recombinant Proteins / Q000008:administration & dosage / Q000627:therapeutic use; D014057:Tomography, X-Ray Computed
D001323:Autoantibodies; D001779:Blood Coagulation Factors; D011994:Recombinant Proteins; D005169:Factor VIII; C103587:recombinant FVIIa; C065655:anti-inhibitor coagulant complex; D015942:Factor VIIa